Results 61 to 70 of about 330 (71)
Some of the next articles are maybe not open access.
SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo
Nature Medicine, 2018Giovanni Germano +2 more
exaly
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
Nature Reviews Clinical Oncology, 2009Nicola Normanno +2 more
exaly
A combinatorial strategy for treating KRAS-mutant lung cancer
Nature, 2016Eusebio Manchado +2 more
exaly
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
Nature Medicine, 2018Jin Zhou, Zhong Wu, Steven E Schumacher
exaly
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer
Cancer Cell, 2019Wen-Ting Liao +2 more
exaly
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
Science, 2016Piro Lito, Lian-Sheng Li, Neal Rosen
exaly

